Functional characterization of NBAT1 as a novel biomarker for neuroblastoma revealed its property as a tumor suppressor, making it a highly attractive target for novel therapeutic strategies for high-risk neuroblastoma patients. This evidence concerns the gene NBAT1 and neuroblastoma.